2022
HPV type‐specific trends in cervical precancers in the United States, 2008 to 2016
Gargano JW, McClung N, Lewis RM, Park IU, Whitney E, Castilho JL, Pemmaraju M, Niccolai LM, Brackney M, DeBess E, Ehlers S, Bennett NM, Scahill M, Cleveland AA, Querec TD, Unger ER, Markowitz LE, Group H. HPV type‐specific trends in cervical precancers in the United States, 2008 to 2016. International Journal Of Cancer 2022, 152: 137-150. PMID: 35904861, DOI: 10.1002/ijc.34231.Peer-Reviewed Original ResearchConceptsHR-HPV typesAverage annual percent changeCross-sectional population-based dataCases of CIN2Individual HPV typesHuman papillomavirus vaccinationCervical intraepithelial neoplasiaIncidence rate ratiosPopulation-based dataConfidence intervalsAnnual percent changeOlder age groupsSignificant declineHPV vaccinationNonvaccine typesPapillomavirus vaccinationHPV typesVaccine impactIntraepithelial neoplasiaIncidence rateCervical precancerCIN2Percent changeAge groupsType replacement
2021
Increases in Human Papillomavirus Testing Preceding Diagnosis of Cervical Precancer in 5 US States, 2008–2016
Cleveland AA, Gargano JW, Griffin MR, Park IU, Niccolai LM, Bennett NM, Pemmaraju M, Fink D, Brackney M, Scahill M, Ehlers SJ, Unger ER, Markowitz LE, Group T. Increases in Human Papillomavirus Testing Preceding Diagnosis of Cervical Precancer in 5 US States, 2008–2016. Journal Of Lower Genital Tract Disease 2021, 25: 192-198. PMID: 33797511, DOI: 10.1097/lgt.0000000000000606.Peer-Reviewed Original ResearchConceptsHPV testProportion of womenCervical precancerCytology resultsAge groupsHuman papillomavirus testingAtypical squamous cellsAtypical glandular cellsCervical intraepithelial neoplasiaWomen 30 yearsCross-sectional analysisHPV testingCervical diseaseIntraepithelial lesionsIntraepithelial neoplasiaSquamous cellsLaboratory surveillanceMost womenUnknown significanceGlandular cellsDiagnosisPrecancerWomenCIN2Years
2018
Trends in High-grade Cervical Lesions and Cervical Cancer Screening in 5 States, 2008–2015
Gargano JW, Park IU, Griffin MR, Niccolai LM, Powell M, Bennett NM, Jones ML, Whitney E, Pemmaraju M, Brackney M, Abdullah N, Scahill M, Dahl RM, Cleveland AA, Unger ER, Markowitz LE, Blankenship S, Allen S, Meek J, Higgins K, Hadler J, Sosa L, Saadeh K, Williamson A, Fink D, Silverberg M, Laing R, Schafer S, Oktapodas M, Felsen C. Trends in High-grade Cervical Lesions and Cervical Cancer Screening in 5 States, 2008–2015. Clinical Infectious Diseases 2018, 68: 1282-1291. PMID: 30137283, PMCID: PMC6783904, DOI: 10.1093/cid/ciy707.Peer-Reviewed Original ResearchConceptsCervical cancer screeningIncidence rate ratiosCancer screeningCervical cancer screening recommendationsPopulation-based laboratory surveillanceAge groupsHigh-grade cervical lesionsHuman papillomavirus vaccine uptakeCancer screening recommendationsCervical intraepithelial neoplasiaPercent of womenHPV vaccinationScreening recommendationsIntraepithelial neoplasiaVaccine uptakeCervical lesionsLaboratory surveillanceCIN2Population-level impactWomenRate ratioSignificant decreaseYearsScreeningAdenocarcinoma